WOOJUNG BIO, Inc.
Offers pre-clinical CRO services, research facility engineering, and startup incubation.
215380 | KO
Overview
Corporate Details
- ISIN(s):
- KR7215380007
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 동탄기흥로 593-8 (영천동, 우정바이오 신약클러스터I), 화성시
Description
WOOJUNG BIO, Inc. is a bio-infrastructure company providing an integrated platform for research and development in the life sciences. The company's core activities are structured around three main pillars. First, it offers comprehensive pre-clinical Contract Research Organization (CRO) services, including efficacy studies, safety evaluations, and pharmaceutical analysis, utilizing its advanced animal laboratory facilities. Second, it specializes in the engineering and construction of modernized research environments, offering complete solutions for building and managing smart laboratories, animal rooms, and GMP-compliant clean rooms. Third, through its 'WOOJUNG BIO Cluster' open innovation platform, it provides R&D infrastructure, incubation, and acceleration support for bio-ventures and startups, aiming to foster the new drug development ecosystem and help transform innovative ideas into therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-13 00:00 |
의결권대리행사권유참고서류
|
Korean | 99.2 KB | ||
| 2025-03-13 00:00 |
주주총회소집결의
|
Korean | 14.7 KB | ||
| 2025-03-13 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.0 KB | ||
| 2025-02-13 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.3 KB | ||
| 2024-12-13 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 77.1 KB | ||
| 2024-12-10 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 39.0 KB | ||
| 2024-12-09 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.4 KB | ||
| 2024-12-05 00:00 |
증권발행결과(자율공시)
|
Korean | 6.3 KB | ||
| 2024-11-20 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 35.7 KB | ||
| 2024-11-20 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 37.8 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 824.1 KB | ||
| 2024-09-06 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 68.8 KB | ||
| 2024-08-23 00:00 |
[기재정정]기타경영사항(자율공시) (전환우선주의 보통주 전환청구)
|
Korean | 13.1 KB | ||
| 2024-08-20 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 20.9 KB | ||
| 2024-08-19 00:00 |
기타경영사항(자율공시) (전환우선주의 보통주 전환청구)
|
Korean | 9.8 KB |
Automate Your Workflow. Get a real-time feed of all WOOJUNG BIO, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for WOOJUNG BIO, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for WOOJUNG BIO, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
